Topics
Glioblastoma | Treatment | Targeted therapy | Aptamers
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Aptamers
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R,
Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC,
Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten
M, Glas M, Seidel C, Herrlinger U, Hölzel M.
L-RNA
aptamer-based CXCL12 inhibition combined with radiotherapy in
newly-diagnosed glioblastoma: dose escalation of the phase I/II
GLORIA trial.
Nat
Commun. 2024 May 28;15(1):4210. doi:
10.1038/s41467-024-48416-9. PMID:
38806504.
Interventional study. ˍ
Chatterjee D, Bhattacharya S, Kumari L, Datta A.
Aptamers:
ushering in new hopes in targeted glioblastoma therapy.
J
Drug Target. 2024 Jul 3:1-24. doi:
10.1080/1061186X.2024.2373306. PMID:
38923419. Review˰ ˍ